National Institute of Communicable Diseases
Directorate General of Health Services
Ministry of Health and Family Welfare (GOI)
22, Sham Nath Marg, New Delhi-110 054

About NICD
About NSPCD
NICD Publications
Downloads
Investigation Reports
Fact Sheet
Training Programmes
Address Directory
Related Sites
What's New?
Annual Tenders?
 
 

ANNUAL REPORT 1997
 
CONTENTS
1.   Introduction
          Organisation Chart
          NICD Faculty/Administration/Staff
          Budget at a Glance (1997)
2.   Objectives and Functions of the Institute
3.   National Health Programmes
          National Surveillance Programme for Communicable Diseases (NSPCD)
          Guinea Worm Eradication Programme (GWEP)
          Yaws Eradication Programme (YEP)
4.   Scientific and Research Activities
       Headquarters
          Division of AIDS & HIV
          Division fo Biochemistry/Biotechnology
          Division of Epidemiology
          Division of Helminthology
          Division of Microbiology
          Division of Medical Entomology/Vector Control
          Division of Training & Malariology
          Division of Zoonosis
       Branches
          Alwar
          Bangalore
          Calicut
          Coonoor
          Jagdalpur
          Patna
          Rajamundry
          Varanasi
5.   Manpower Development/Training Courses, Workshops, Seminars
6.   Outbreak Investigations
7.   Participation in Conferences, Workshops, Seminars and Symposia
8.   WHO/Other International Fellowships
9.   Membership of Expert Committes/Advisory Panel/Honours
10. Important Visitors during the Year
11. Publications/Presentations
Annexures
          Central Library
          Central Animal Facility

Top

4. Scientific & Research Activities

Division of AIDS

§         The division of AIDS has the following units.

§         HIV serology and quality control (incorporating the National reference centre for HIV/AIDS).

§         Epidemiology, training and counselling.

§         Immunology of HIV infection and AIDS.

§         AIDS associated diseases and STDs.

HIV SEROLOGY AND QUALITY CONTROL

Diagnostic Services

During 1997, blood samples from individuals of different high risk behaviours were tested for HIV infection by different screening tests viz. EIA, Dot Immunoassay & agglutination test, followed by confirmatory WB test.

 

 

No. of samples tested by various tests

 

 

Categories & Sources of Samples

No. of samples tested

EIA

Dot immunoassay assay (Immuno comb)

Agglutination test (Capillus)

Confirmatory (Innolia test)

No. of samples found Positive

Total tests performed

Collected by NICD under surveillance centre (after counselling)

1411

1411

797

1411

129

129

3748

Referred from other institutions (for confirmation of pre tested HIV status)

826

826

700

826

696

696

3048

HIV screening of blood products of human origin (Received through DCI)

262

262

-

262

-

NIL

524

HIV screening activities on foreign students.

Foreign students coming to Delhi and adjacent states viz. UP, Rajasthan, Punjab etc. for study in different universities of north India were screened for HIV infection. A total of 642 foreign students have been screened during 1997, with only 1 case found to be positive for HIV by WB test. The details of such HIV positive cases for the last nine years is shown in the graph below:

Distribution of HIV positivity among foreign students (Years 1989 to 1997)

African countries comprising of Ethiopia, Uganda, Somalia, Kenya, Namibia, Tenzania and Zambia-constituted 89% of HIV positivity and Asian countries constituted 11%.

          Male female ratio = 82:18

          Age group wise (15-22) yrs      13 (33%)                 (31-40) Yrs     2 (5%)

          Break up        (23-30) yrs    22 (56%)           40 yrs >         2 (5%)  

Evaluation of diagnostic test kits for HIV

The various diagnostic kits (indigenous as well as imported) were evaluated with the help of standard panel of sera maintained in the laboratory.

A total of 6 (six) different kits have been evaluated in 1997 for their performance characteristics, viz. sensitivity specificity, predictive value and delta value. The results were intimated to the Drug Controller of India

Details of evaluation of HIV test kits (1997)

 

 

 

 

Test kit performance characteristics

 

Sr. No.

 

Manufacturer dt. of expiry

No. of kits evaluated

Type of assav

Sensitivity

Specificity

PPV

NPV

Approx. time reqd. for test performance

 

Indigenous

 

 

 

 

 

 

 

 

 

1.

Comb AIDS

Span Diagnostic Ltd.  Surat (Gujarat) February 1998

3 (three) kits

Visual

100%

100%

100%

100%

30 minutes for 46 tests

2.

MICROLISA-HIV

J.Mitra & Co. Ltd. Okhla New Delhi Dt. Of Expiry Nov.’97

2 kits (two)

EIA

100%

98.8%

98.7%

100%

Three hour for tests

3.

HIV-CHEX ELISA

Xcyton Diagnostic Pvt. Ltd. Bangalore Dt. of Expiry 15.1.98

3 (three) kits

EIA

99.3%

99%

99.2%

99.4%

Two hours for tests

 

Imported

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1.

Novapath HIV-1/2 EIA

Bio-Rad Laboratories and United Biomedical Inc. B Oct.’97

2 kits (two)

EIA

99.5%

99.3%

99.3%

99.2%

2 hrs. for 96 tests

2.

HIV-Logic (rapid) HIV-I & HIV-2

Pace Diagnosis Inc. Richmond Hill Canada Feb.’98

5 kits (five)

Visual

99.6%

99.8%

99.4%

99.3%

25 minutes for  tests

3.

INSTANT CHEK HIV1+2

EY Laboratories Inc. by E-y laboratories (H.K.) Ltd. July 1997

4 (four) kits

Visual

100%

100%

100%

100%

10 minutes for  tests

PPV = Positive Predictive Value

NPV = Negative Predictive Value

Evaluation of HIV screening test kits for HIV antibodies in saliva

Evaluation of HIV screening test kits for saliva samples, in comparison to conventional serology have been undertaken & still being continued. So far 21 saliva samples have been tested which showed about 95% correlation with conventional HIV serology.

Participation in quality control programme

National

Serum samples have been received from various centres (Zonal Blood Testing Centres & Sero-surveillance centres located in Delhi) for cross checking of results for HCV & HBsAg, as a part of quality control services.

Sr. No.

Name of Blood Banks

HBsAg

HCV

 

 

No. of Reactive samples cross checked

% Giving discordant results

No. of Reactive Samples cross checked

% Giving discordant results

1.

Blood Bank, Pussa Road, New Delhi

-

-

15

Nil

2.

Sunil Blood Bank & Transfusion Centre. New Delhi

2

Nil

-

-

3.

Bajaj Blood Bank New Delhi

-

-

8

Nil

4.

RML Hospital, New Delhi

6

16%

2

0

5.

IRCS Blood Bank New Delhi

19

37%

-

-

6.

Rajiv Gandhi Cancer Institute, New Delhi

65

21.5%

8

3%

7.

AFTC New Delhi

11

44%

8

100%

8.

G.B. Pant Hospital, New Delhi

16

6%

-

-

9.

E.S.I. Hospital, New Delhi

7

42%

6

100%

10.

National Heart Institute, New Delhi

6

83%

2

0%

11.

L.N.J.P. Hospital, New Delhi

-

-

7

85%

12.

CNC Blood Bank AIIMS New Delhi

55

60%

55

90%

 

* Discordant results on account of use of different types of test and test kits. Gold Standard for HBsAg and HCV has not been used. The procedure is being standardized for HCV presently.

International

AIDS reference centre of NICD has been participating in WHO proficiency program since 1990 and still continuing to participate in the same program. In 1997, three proficiency panels of sera were received & tested. The details are shown in the table.

 

 

 

 

 

NICD-DELHI

 

 

AUSTRALIA

Panel

No. of

Type

EIA

Capilus

W.B.

SR

No.

Sample

 

Neg

Pos

Neg

Pos

Neg

Pos

Neg.

Pos.

3

14

Serum samples

7

7

8

6

8

6

8

6

4

10

DDS

5

5

8

2

4

6

4

6

5

10

DDS

5

5

8

2

4

6

4

6

DDS – Dried Disc Serum (Filter Paper disc)             SR – Sample Reactive

100% Correlation by Confirmatory W. Blot performed at NICF & Australia. There was only one discrepant result out of 34 samples as was mentioned in the report received from the organising centre in Australia.

Epidemiology, Training & counselling services

This division receives the HIV screening reports from various ZBTCs & surveillance centres.

The bar diagram projected below shows various sero-reactivity rates by EIA per thousand samples of donated blood screened in six reporting states.

A comparison study of Knowledge, Attitude & Practice on HIV/AIDS has been conducted between two groups of students, one Indian and the other of foreign countries (300 students from each group) during 1997. Data so obtained is in the process of compilation and analysis.

Counselling services

The various categories of persons, having different kinds of risk behaviours, who voluntarily reported to NICD for HIV infection testing, have been given pre-test & post-test counselling; preventive counselling was given to people in close contact with HIV infected persons. A total of 131 such persons were given counselling during 1997.

Complied data of the persons given counselling

Age Groups of Individuals

Major Risk Groups

Sex

0-12

13-20

21-25

26-30

31-35

35>

S.P.

IVDU

B.T.R.

P-HIV (+ve)

 

SHAI

CL

NDRG

M

2

6

13

25

26

26

60

5

8

-

 

6

12

7

F

0

4

12

7

6

4

-

-

1

11

 

-

16

5

SP = Sexual Promiscuity              IVDU = Intra Venous drug users          BTR = Blood Transfusion recipient CL = Clinical cases

P-HIV (+ve) = Sexual Partner of HIV positive person        SHAI = Suspected Hospital acquired infection NDRG = No Definite Risk  

Group

AIDS related diseases and STD infections

The AIDS associated diseases and STD laboratory was set up in the last quarter of 1996 and comprises of two units.

Unit – I (STD Laboratory)

§         The STD laboratory is engaged in the study on prevalence of STDs in population attending hospital and STD clinics.

§         The STD laboratory had been carrying out Gonococcal Antibiotic Susceptibility testing as a participating laboratory of Gonococcal Antibiotic Susceptibility Programme (GASP, WHO), being co-ordinated by AIIMS, New Delhi.

The procedure of Gonococcal identification and antibiotic sensitivity tests were according to Standard Operating Procedure Manual from GASP.

The summary of the antimicrobial sensitivity pattern of N. gonorrhoea observed in the laboratory is shown below:

Aantimicrobial sensitivity pattern of N. gonorhoea

 

Antibiotics

Total number of strain tested

Sensitive (%)

Resistant (%)

Penicillin G (10 i.u.)

8

4 (50)

4 (50)

Ciprofloxacin 5mcg.

8

8 (100)

0

Nalidixic and 30mcg.

8

5 (62.5)

3 (37.5)

Tetracycline 30mcg.

8

6 (75)

2 (25)

Ceftriaxone 300mcg.

1

1

 

          Serological diagnosis of common STI agents carried out in the STI unit

Categories of STDs

No. Screened

No. positive (%)

T. pallidum    RPR

                       TPHA

1264

125 (9.9)

HSVI              IgG

                        IgM

103

78

79 (76.6)

0

HSV2              IgG

                        IgM 

193

68

142 (73)

2 (2.9)

HIV

679

11 (1.6)

Chalmydia      (IgG)

88

3 (3.4)

HBV

100